|Titre :||Cannabis use and dependence among French schizophrenic inpatients (2014)|
|Auteurs :||M. LEJOYEUX ; A. BASQUIN ; M. KOCH ; H. EMBOUAZZA ; F. CHALVIN ; M. ILONGO|
|Type de document :||Article : Périodique|
|Dans :||Frontiers in Psychiatry (Vol.5, 2014)|
|Article en page(s) :||art. 82 ; 6 p.|
|Discipline :||PSY (Psychopathologie / Psychopathology)|
Thésaurus TOXIBASECANNABIS ; SCHIZOPHRENIE ; CONSOMMATION ; DEPENDANCE ; ETUDE CLINIQUE ; HOSPITALISATION ; COMPARAISON
Background: To assess the prevalence of cannabis use and dependence in a population of schizophrenic inpatients and to compare schizophrenics with and without cannabis consumption.
Methods: One hundred one schizophrenic patients were examined during their first week of hospitalization. They answered the PANNS scale of schizophrenia, the CAGE and the Fagerström questionnaire, and the DSM-IV-TR criteria for cannabis, alcohol, opiates, and nicotine use dependence were checked. We also assessed socio-demographic characteristics, the motive of cannabis consumption, and the number of cannabis joints and alcoholic drinks taken.
Results: The prevalence of cannabis consumption was 33.6% among schizophrenic inpatients. Schizophrenics consuming cannabis were younger than non-schizophrenics (33.3 vs. 44.7 years p Conclusion: 33.6% of the schizophrenic patients hospitalized in psychiatry consume cannabis and most of them are dependent on cannabis and alcohol. Hospitalization in psychiatry may provide an opportunity to systematically identify a dependence disorder and to offer appropriate information and treatment.
|Domaine :||Drogues illicites / Illicit drugs|
|Refs biblio. :||21|
|Affiliation :||Department of Psychiatry and Addictive Medicine, Maison Blanche Hospital, Bichat-Claude Bernard Hospital, AP-HP, Paris Diderot University, Paris, France|